UBS Call 130 ABL 21.03.2025/ CH1327414731 /
09/09/2024 19:30:59 | Chg.+0.099 | Bid21:50:09 | Ask21:50:09 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.290EUR | +51.83% | - Bid Size: - |
- Ask Size: - |
ABBOTT LABS | 130.00 - | 21/03/2025 | Call |
GlobeNewswire
06/08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer